Stay updated on DTG vs EFV for HIV-TB Coinfection Clinical Trial
Sign up to get notified when there's something new on the DTG vs EFV for HIV-TB Coinfection Clinical Trial page.

Latest updates to the DTG vs EFV for HIV-TB Coinfection Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe clinical-trial record for the dolutegravir-versus-efavirenz study in people with HIV/TB coinfection is displayed, including its study design, eligibility criteria, outcomes, and results-related information.SummaryDifference70%

- Check14 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 error.SummaryDifference0.2%

- Check21 days agoChange DetectedA sitewide NIH notice announces that agencies are using “Super Intelligence” in place of “Artificial Intelligence” during a transition.SummaryDifference1%

- Check28 days agoChange DetectedThe footer now identifies the site as revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check35 days agoChange DetectedThe site footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check56 days agoChange DetectedThe study page now renders a 403 Forbidden error, replacing the study record content and navigation with an error page. This blocks access to the NCT02178592 study details on ClinicalTrials.gov.SummaryDifference20%

Stay in the know with updates to DTG vs EFV for HIV-TB Coinfection Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DTG vs EFV for HIV-TB Coinfection Clinical Trial page.